Science
Pipeline
About Us
News & Media
Resources
Investors
Contact Us

Science
Pipeline
About Us
News & Media
Resources
Investors
Contact Us

Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases

steve | 5 February 2019

Categories:

Post navigation

← STEM Trial: SFX-01 in the Treatment and Evaluation of Metastatic breast cancer, presented at the San Antonio Breast Cancer Symposium 2018

STEM Headline Results presentation, 25 March 2019 →

Copyright© 2024
ICO Reg: ZB396415
Company Number: 09246681

Website Privacy Policy and Cookie Policy
Sitemap